Molecular Diagnostics: The Key in Personalized Cancer Medicine | Agenda Bookshop Skip to content
Black Friday Sale Now On! | Buy 3 Get 1 Free on all books | Instore & Online.
Black Friday Sale Now On! | Buy 3 Get 1 Free on all books | Instore & Online.
Age Group_Uncategorized
Age Group_Uncategorized
automatic-update
B01=Henrik Winther
B01=Jan Trost Jorgensen
Category1=Non-Fiction
Category=MB
Category=MJCL
Category=MMF
Category=PS
Category=TDCW
COP=Singapore
Delivery_Pre-order
Language_English
PA=Temporarily unavailable
Price_€100 and above
PS=Active
softlaunch

Molecular Diagnostics: The Key in Personalized Cancer Medicine

English

This unique book provides a thorough overview of developing molecular cancer diagnostic assays, which are the prerequisites for optimal solutions within personalized cancer medicine. The book takes the reader through definitions of the pharmacodiagnostic concept, historical perspectives of the early steps into molecular cancer diagnostics linked to therapy, the basis of different diagnostic molecular techniques, ongoing research, drug-diagnostic co-development, assay validation, clinical trial methodology, regulatory issues around pharmacodiagnostics and future aspects within personalized cancer medicine.

See more
Current price €127.29
Original price €133.99
Save 5%
Age Group_Uncategorizedautomatic-updateB01=Henrik WintherB01=Jan Trost JorgensenCategory1=Non-FictionCategory=MBCategory=MJCLCategory=MMFCategory=PSCategory=TDCWCOP=SingaporeDelivery_Pre-orderLanguage_EnglishPA=Temporarily unavailablePrice_€100 and abovePS=Activesoftlaunch

Will deliver when available.

Product Details
  • Weight: 703g
  • Dimensions: 152 x 229mm
  • Publication Date: 30 Apr 2010
  • Publisher: Pan Stanford Publishing Pte Ltd
  • Publication City/Country: Singapore
  • Language: English
  • ISBN13: 9789814241441

About

Dr Jan Trøst Jørgensen holds an MSc degree in pharmacy and a PhD in clinical pharmacy from the Faculty of Pharmaceutical Sciences University of Copenhagen. He has worked with drug development in biotech and pharmaceutical companies for more than 25 years and within the last 10 years his focus has been on drug-diagnostic co-development projects within cancer. Dr Jørgensen is a strong supporter of more individualized pharmacotherapy and has published a number of scientific papers on oncology as well as on stratified and personalized medicine.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept